Understanding Parp Inhibitors
Exploring Parp Inhibitors reveals several interesting facts. Just like normal cells, cancer cells have ways of repairing damage that occurs to them. In this episode of Science Illustrated we ...
Key Takeaways about Parp Inhibitors
- Dr. Amanika Kumar and Dr. Andrea Wahner Hendrickson discuss
- Dr Jon Krell, Consultant Medical Oncologist, talks to our Cancer Prevention Officer Jo Stanford all about
- In May 2018, Mayo Clinic hosted a gynecologic cancer education course for ovarian cancer survivors and caregivers. Dr. Andrea ...
- PARP inhibitors
- Explore the recent developments and clinical updates on
Detailed Analysis of Parp Inhibitors
First of new generation of cancer drugs granted European approval A new drug for ovarian cancer, developed by researchers at ... Shannon Westin, MD, gives a brief overview of PARP inhibitors
In 2020, olaparib (Lynparza) and rucaparib (Rubraca) were FDA-approved for the treatment of men with castrate-resistant prostate ...
Stay tuned for more updates related to Parp Inhibitors.
